Mechanistic Integration of Network Pharmacology and In Vivo Validation: TFRD Combat Osteoporosis via PI3K/AKT Pathway Activation
Open Access
- 12 April 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8) , 3650
Abstract
In the context of osteoporosis closely linked to bone metabolism imbalance caused by estrogen deficiency, total flavonoids of Rhizoma Drynariae (TFRD) exhibit potential anti-osteoporotic activity, yet their multicomponent synergistic mechanism and association with the PI3K/AKT signaling pathway remain unclear. This study aimed to systematically elucidate the molecular mechanisms by which TFRD regulate bone metabolism and improve osteoporosis in ovariectomized (OVX) rats through the PI3K/AKT pathway, integrating network pharmacological predictions with animal experimental validation. Methods involved identifying TFRD’s active components using UPLC/MS-MS, predicting targets with SwissTargetPrediction, constructing a “component-target-disease” network, and performing GO/KEGG enrichment analysis with MetaScape (v3.5). In vivo experiments established an OVX rat model, randomized into sham, OVX, low-/high-dose TFRD, and sim groups, assessing bone mineral density (BMD) and mandibular Micro-CT parameters after 12 weeks. Western blot analyzed PI3K, p-AKT1, and related protein expressions. Results showed the high-dose TFRD group significantly increased BMD, improved trabecular bone quantity and structure, and upregulated PI3K, p-PI3K, and p-AKT1 protein expressions compared to the OVX group. Molecular docking confirmed stable binding energy between core components and PI3K/AKT targets. TFRD may ameliorate estrogen deficiency-induced osteoporosis by activating the PI3K/AKT signaling pathway, inhibiting bone resorption, and promoting osteogenic differentiation, providing pharmacological evidence for multitarget treatment of osteoporosis with traditional Chinese medicine.Keywords
Funding Information
- Youth Fund of the National Natural Science Foundation of China (81904067, 81904067)
- Youth Fund of the National Natural Science Foundation of China (81904067, 81904067)
- National Administration of Traditional Chinese Medicine 2021 Qihuang Scholar Support Project (National TCM Education Letter 2022 No. 6) (81904067, 81904067)
This publication has 36 references indexed in Scilit:
- Jaw osteoporosis: Challenges to oral health and emerging perspectives of treatmentBiomedicine & Pharmacotherapy, 2024
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signalingPhytomedicine, 2024
- Total flavonoids of Rhizoma drynariae promote angiogenesis and osteogenesis in bone defectsPhytotherapy Research, 2022
- Effect of flavonoids from Rhizoma Drynariae on osteoporosis rats and osteocytesBiomedicine & Pharmacotherapy, 2022
- PANTHER: Making genome‐scale phylogenetics accessible to allProtein Science, 2021
- Postmenopausal OsteoporosisEndocrinology and Metabolism Clinics of North America, 2021
- Osteoporosis in Older AdultsMedical Clinics of North America, 2020
- The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative reviewOsteoarthritis and Cartilage, 2020
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis FoundationOsteoporosis International, 2015